Skip to content
November 24, 2024

Investment information for the new generation

Search

NCNA.Q

NuCana PLC (NCNA.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Acerlarin® (NUC-1031), which is currently being evaluated in a Phase…